CovalX and the Swiss Federal Institute of Technologie (IMSB, Prof. Ruedi Aebersold) started a research project focus on the development of new methodology for the characterization of monoclonal antibody epitopes. The research project is supported by the Swiss Commission of Technology and Innovation (KTI) and CovalX.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.